Bengaluru: Syngene International, a listed subsidiary of Biocon Limited, has announced the appointment of Peter Bains as an ...

Furthermore, Biocon has scheduled a board meeting on April 4 to discuss and approve fundraising for its commercial business ...

Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/04/2025 ,inter alia, to consider and approve Intimation of Board meeting for raising funds throu ...

The approval covers the norepinephrine bitartrate injection 4 mg/4 mL (1 mg/mL) single-dose vial, which can now be ...

Johor is set to become Asia's largest insulin hub as India's leading biotechnology firm, Biocon Ltd, invests another RM1.1 ...

Kiran Mazumdar Shaw, Biocon Limited's executive chairperson, criticized Bengaluru's streets, comparing them unfavorably to ...

Biocon Pharma Limited receives FDA approval for Norepinephrine Bitartrate Injection USP, expanding its complex drug portfolio ...

AM(IST)on Tuesday in a weak market. Dr. Reddy's Laboratories Ltd.(up 1.46 per cent), Biocon Ltd.(up 1.35 per cent), Natco ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

BRIDGEWATER, N.J., and BENGALURU, India, March 7, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code ...